Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S.

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some of the most expensive medications.

The Indian Pharmaceutical industry is ranked third in pharmaceutical production by volume, is expected to grow 9-11 percent in the financial year 2024. According to IBEF, the industry is expected ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Japan was once the second biggest pharma market in the world behind the US ... 59% of 41 Japanese pharma companies in an online survey predicted biosimilars will be the fastest growing sector.

Analysis-Pharma Companies Expected to Absorb Any Tariff ... but the industry has been lobbying for phased-in tariffs. The hit could be big. Close to $213 billion in pharmaceutical products were ...